Resources 
Product Resource
Learning
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, and HEK293 Cell Lines Officially Secured.
ExploreArticles
From Inflammation to Cancer: Biological Functions of the CCL2-CCR2 Axis and New Progress in Targeted Drug R&D
As our understanding of the tumor microenvironment deepens, targeting the CCL2-CCR2 axis is transitioning from concept to clinical reality. Whether you are developing small molecule inhibitors, neutralizing antibodies, or novel ADCs, reliable screening models are the cornerstone of success. Reqbio remains committed to focusing on frontier targets in GPCRs and immuno-oncology, providing high-quality biological reagents and cell models to empower global innovative drug discovery.
Unlocking the Dual Potential of ICOS: The Next Frontier in Immuno-Oncology and ICOS (CD278) Cell Model Solutions
With the deepening understanding of ICOS biology and the optimization of combination therapy strategies, this target holds great promise for the development of breakthrough therapeutics in the near future. Renkun Biotech remains committed to providing high-quality biological reagents and cell models to empower innovative drug discovery worldwide. Whether you are developing novel ICOS antibodies or exploring combination therapies, our tools are designed to accelerate your research from the lab to the clinic.
Focusing on the IL-17 Target: The "Golden Track" of Autoimmune Drug R&D and Essential Tool Models
ReqBio remains committed to the frontiers of immunotherapy, providing high-quality biological reagents and cell models to help global researchers conquer autoimmune diseases.
NFAT Signaling Pathway: A Critical Target for Drug R&D and Cell Models
Reqbio provides professional NFAT signaling pathway research solutions, featuring functionally validated NFAT-Luc reporter gene cell models (Jurkat, HEK293, THP-1, CHO). Our cell models are ideal tools for screening NFAT inhibitors (such as Cyclosporine A), developing immunotherapies, and studying the mechanisms of cancer and autoimmune diseases. Covering NFAT1-5 targets, our products facilitate target validation and high-throughput drug screening.
TSHR Cell Model for Thyroid Cancer Drug Screening | GPCR Assay Platform-Reqbio
Reqbio provides professional TSHR cell models (CRE-Luc HEK293/CHO) for thyroid cancer targeted drug screening, GPCR signaling research, and reporter gene assays. Explore 1500+ ready-to-use models for drug R&D and bioassay services.
MC4R – A Niche Target in Weight Loss
MC4R (melanocortin 4 receptor) is a member of the melanocortin receptor family, which belongs to the rhodopsin-like class A GPCR family.
